Table 2.
Resistance Phenotypes and Comparison of Carbapenem-Resistant Pseudomonas aeruginosa with Carbapenem-Sensitive P. aeruginosa
| CR-PA | CS-PA | Total (%) | p | |
|---|---|---|---|---|
| AK | 23.33 | 0 | 7.07 | 0.000 |
| ATM | 26.67 | 14.46 | 17.70 | 0.222 |
| CAZ | 36.67 | 3.61 | 12.39 | 0.000 |
| CIP | 53.33 | 15.66 | 26.55 | 0.000 |
| CSL | 36.67 | 6.02 | 15.04 | 0.000 |
| FEP | 36.67 | 0 | 9.73 | 0.000 |
| GEN | 16.67 | 6.02 | 9.73. | 0.079 |
| IPM | 93.33 | 0 | 23.89 | — |
| LEV | 56.67 | 16.87 | 27.4 | 0.000 |
| MEM | 86.67 | 0 | 23.0 | — |
| PIP | 36.67 | 13.25 | 19.46 | 0.006 |
| TOB | 30.00 | 4.81 | 12.39 | 0.001 |
| TZP | 30.00 | 6.02 | 12.39 | 0.001 |
AK, amikacin; ATM, aztreonam; CAZ, ceftazidime; CIP, ciprofloxacin; CR-PA, carbapenem-resistant P. aeruginosa; CSL, cefoperazone/sulbactam; CS-PA, carbapenem-sensitive P. aeruginosa; FEP, cefepime; GEN, gentamicin; IPM, imipenem; LEV, levofloxacin; MEM, meropenem; PRL, piperacillin; TOB, tobramycin; TZP, piperacillin/tazobactam.